How Many Mutant p53 Molecules Are Needed To Inactivate a Tetramer?
AUTOR(ES)
Chan, Wan Mui
FONTE
American Society for Microbiology
RESUMO
The tumor suppressor p53 is transcription factor composed of four identical subunits. The majority of the mutations in p53 are missense mutations that impair DNA binding. On the other hand, the p53-related p63 and p73 genes are rarely mutated, but many cell types express natural variants lacking the N-terminal transactivation domain (NΔ). Compelling evidence indicates that both the DNA binding-defective and NΔ mutants can impair the function of wild-type p53 in a dominant-negative manner. Interestingly, it is uncertain how many mutant subunit(s) a p53 tetramer can tolerate. In this study, we first made theoretical predictions based on the number of mutant p53 monomers needed to inactivate a tetramer and then tested how well the experimental data fit the predicted values. Surprisingly, these experiments reveal that DNA binding-defective p53 mutants (R249S and R273H) are very ineffective in impairing the transcriptional activity of p53: at least three mutants are required to inactivate a tetramer. In marked contrast, p53NΔ is a very potent inhibitor of p53: one NΔ subunit per tetramer is sufficient to abolish the transcriptional activity. DNA binding is not necessary for the NΔ proteins to inactivate p53. Similarly, NΔ variants of p63 and p73 are also powerful inhibitors of members of the p53 family. These results have important implications for our thinking about the mechanism of tumorigenesis involving missense p53 mutants or the N-terminally truncated isoforms.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=381690Documentos Relacionados
- How many microbiology consultants are needed?
- The p53 protein is an unusually shaped tetramer that binds directly to DNA.
- Phosphorylation at Ser-15 and Ser-392 in mutant p53 molecules from human tumors is altered compared to wild-type p53.
- Synthetic small inhibiting RNAs: Efficient tools to inactivate oncogenic mutations and restore p53 pathways
- Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.